These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38844444)

  • 21. Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults.
    Adams JN; Harrison TM; Maass A; Baker SL; Jagust WJ
    J Neurosci; 2022 Feb; 42(7):1352-1361. PubMed ID: 34965972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.
    Sintini I; Martin PR; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Spychalla AJ; Drubach DA; Knopman DS; Petersen RC; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Neuroimage Clin; 2019; 23():101823. PubMed ID: 31004914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau positron emission tomography in preclinical Alzheimer's disease.
    Insel PS; Young CB; Aisen PS; Johnson KA; Sperling RA; Mormino EC; Donohue MC
    Brain; 2023 Feb; 146(2):700-711. PubMed ID: 35962782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.
    Chen X; Cassady KE; Adams JN; Harrison TM; Baker SL; Jagust WJ
    J Neurosci; 2021 Jan; 41(2):366-375. PubMed ID: 33219003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
    Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
    J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.
    Sepulcre J; Grothe MJ; d'Oleire Uquillas F; Ortiz-Terán L; Diez I; Yang HS; Jacobs HIL; Hanseeuw BJ; Li Q; El-Fakhri G; Sperling RA; Johnson KA
    Nat Med; 2018 Dec; 24(12):1910-1918. PubMed ID: 30374196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    Sedghizadeh MJ; Hojjati H; Ezzatdoost K; Aghajan H; Vahabi Z; Tarighatnia H
    PLoS One; 2020; 15(12):e0243535. PubMed ID: 33320870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET Imaging of Tau Deposition in the Aging Human Brain.
    Schöll M; Lockhart SN; Schonhaut DR; O'Neil JP; Janabi M; Ossenkoppele R; Baker SL; Vogel JW; Faria J; Schwimmer HD; Rabinovici GD; Jagust WJ
    Neuron; 2016 Mar; 89(5):971-982. PubMed ID: 26938442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
    Tian Q; Bilgel M; Moghekar AR; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2022; 86(3):1275-1285. PubMed ID: 35180111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Widespread distribution of tauopathy in preclinical Alzheimer's disease.
    Schultz SA; Gordon BA; Mishra S; Su Y; Perrin RJ; Cairns NJ; Morris JC; Ances BM; Benzinger TLS
    Neurobiol Aging; 2018 Dec; 72():177-185. PubMed ID: 30292840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC
    Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.
    Sepulcre J; Grothe MJ; Sabuncu M; Chhatwal J; Schultz AP; Hanseeuw B; El Fakhri G; Sperling R; Johnson KA
    JAMA Neurol; 2017 Jul; 74(7):813-820. PubMed ID: 28558094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.